"High blood pressure and diabetes are two important risk factors...
Category:
Health
Latest
Ensure sustainable fund for Lysosomal Storage Disorders, other rare diseases: MPs to Health Ministry
Nearly 50 per cent of new cases occur in children, causing 35 per...
Common artificial sweetener linked with increased heart attack, stroke risk: Study
The study, published in the journal Nature Medicine, found that...
Policyholders can now opt for renewal, migration and portability of their standard Covid covers:IRDAI
In respect of Corona Kavach individual policies, insurers have the choice to offer migration to any other indemnity based health insurance product offered by them as per the option exercised by the policyholder.
These short term policies are permitted to be renewed till 31st March,2021.
Treat as rep PIL for minimum standards for mental health establishments: HC to Centre
The petition had said there are many establishments in the country which claim they can cure or treat mentally ill people through Ayurveda, Yoga and Naturopathy.
“However, these establishments never register themselves with the Central Mental Health Authority or State Mental Health Authority as required under the Mental Healthcare Act, 2017.
As globe gallops into vaccine trials, insurers remain unfazed
While more than 40 experimental COVID-19 vaccines are being tested on humans, the insurance companies with decades of experience in assessing the risks of clinical trials don’t see anything to be unduly concerned about.
Executives at insurer Allianz and brokers Gallagher and Marsh, among the leading players in clinical trials insurance, told Reuters that premiums had only marginally increased so far in the current pandemic
COVID-19 school closure may cost over USD 400 billion to India, cause learning losses: World Bank
“Temporary school closures in all South Asian countries have had major implications for students. They have kept 391 million students out of school in primary and secondary education, further complicating efforts to resolve the learning crisis,” said the report.
J&J pauses COVID-19 vaccine trials due to unexplained illness in participant
J&J’s move follows a similar one by AstraZeneca Plc. In September, AstraZeneca AZN.L paused late-stage trials of its experimental coronavirus vaccine, developed with the University of Oxford, due to an unexplained illness in a UK study participant.
Worst is over, economic recovery faster than expected: HDFC CEO Keki Mistry
The veteran financial sector player also said that most of the job losses during COVID-19 were confined to low-income workers and the job losses for the kind of people who borrow money were not alarming.
The non-performing individual loans could be in the range of 2.5-4 per cent, which is also the extent of loans that the RBI has allowed to restructure, Mistry added.
COVID-19 cases in India cross 70-lakh mark,fatality rate at 1.54 per cent
The health ministry stressed that more than 70 per cent of the deaths occurred due to comorbidities.
The national recovery rate stands at 86.17 per cent.
The COVID-19 caseload mounted to 70,53,806 with 74,383 infections being reported in a day, while the death toll climbed to 1,08,334 with 918 people succumbing to the disease in a span of 24 hours, the data updated at 8 am showed.
According to the ICMR, a cumulative total of 8,68,77,242 samples have been tested up to October 10 with 10,78,544 samples being tested on Saturday.
Digital healthcare to witness exponential growth in next 5 years: Practo CEO
The healthcare as an overall sector in India is close to USD 200 billion in size and just a single digit of it is online today, Practo co-founder and CEO Shashank ND
Digital adoption in healthcare is still very small and 90 per cent of healthcare is still offline today. So for the companies like Practo, there is a long way to go, he added.
“I expect that this single digit will grow into 20-30 per cent in the next 5-10 years and that is going to be a real big jump for the sector,” Shashank told PTI.
Emergency use authorization for COVID-19 vaccine to depend on clinical trial data
Categorically rejecting speculation that the government is prioritizing young and working-class for the COVID-19 vaccine for economic reasons, Union Health Minister Harsh Vardhan said, the prioritisation of groups for COVID-19 vaccine shall be based on two key considerations — occupational hazard and risk of exposure to infection, and the risk of developing severe disease and increased mortality
Novel coronavirus can last 28 days on glass, currency, Australian study finds
CSIRO researchers found that at 20 degrees Celsius (68 degrees Fahrenheit) the SARS-COV-2 virus remained infectious for 28 days on smooth surfaces such as plastic banknotes and glass found on mobile phone screens. The study was published in Virology Journal.
“It really reinforces the importance of washing hands and sanitising where possible and certainly wiping down surfaces that may be in contact with the virus,” said the study’s lead researcher Shane Riddell.
By comparison, Influenza A virus has been found to survive on surfaces for 17 days.